Allena Pharmaceuticals [ALNA] - Last Close: $0.0780
Allena Pharmaceuticals is skyrocketing after some sharp price moves.
The pharma stock has suffered some major declines as of late, especially in the wake of its recent announcement of a $2.8 million direct offering.
The stock lost 9.0% on Wednesday, but the chart might be showing signs that the sell-off is bottoming out.
Today, ALNA is surging to a huge gain ahead of the opening bell despite no major news on the stock.
It could be a signal that investors are beginning to see value in the stock, or it could be a targeted pump-and-dump. Either way, the stock is up big.
ALNA is this morning's most active stock, and it's up 90.5%.
Salarius Pharmaceuticals [SLRX] - Last Close: $0.1600
Salarius Pharmaceuticals is rallying on promising regulatory news.
The clinical-stage biotech company announced after Wednesday's closing bell that it had successfully completed its pre-Investigational New Drug meeting process for SP-3164 for use in hematological cancers and solid tumors.
Salarius plans to submit an IND application in 2023 for the drug candidate, and the company obtained valuable clinical input from the meeting with regulators from the US Food & Drug Administration.
The company plans to initiate its first clinical trials for the drug in 2023 upon receiving IND clearance from the FDA.
News of the regulatory progress is lifting SLRX to a 38.8% gain, and it's one of this morning's most actively-traded stocks.
